论文部分内容阅读
目的:探讨乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法:对2012年8月至2015年6月我院收治的68例重症急性胰腺炎患者作为研究对象,采取随机数字表法分为研究组和常规组,每组34例;常规组单一应用奥曲肽治疗,研究组在对照组用药基础上加用乌司他丁治疗,对比分析两组临床疗效。结果:通过治疗后,研究组的尿、血清淀粉酶恢复正常时间明显低于常规组(P<0.05);研究组总有效率达到97.1%,高于常规组的(85.3%,P<0.05)。结论:在重症急性胰腺炎临床治疗中,采取乌司他丁联合奥曲肽治疗,可有效改善患者病症,临床效果显著,具有重要的临床推广价值。
Objective: To investigate the clinical effect of ulinastatin and octreotide in the treatment of severe acute pancreatitis. Methods: Sixty-eight patients with severe acute pancreatitis treated in our hospital from August 2012 to June 2015 were enrolled in this study. The patients were randomly divided into study group and conventional group (34 cases in each group) Treatment, the study group in the control group based on the use of ulinastatin treatment, comparative analysis of two groups of clinical efficacy. Results: After treatment, the urinary and serum amylase recovery time in the study group was significantly lower than that in the conventional group (P <0.05). The total effective rate in the study group was 97.1%, higher than that in the conventional group (85.3%, P <0.05) . Conclusion: In the clinical treatment of severe acute pancreatitis, ulinastatin combined with octreotide treatment can effectively improve the patient’s condition, the clinical effect is significant and has important clinical value.